Value Aligned Research Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-38,500
Closed -$2.3M 85
2025
Q1
$2.3M Buy
38,500
+30,300
+370% +$2.8M 0.17% 34
2024
Q4
$190K Buy
+8,200
New +$770K 0.05% 35
2024
Q3
Sell
-200
Closed -$1.5K 34
2024
Q2
$1.5K Buy
+200
New +$13.9K ﹤0.01% 29

Other funds holding ALAB

Value Aligned Research Advisors's ALAB Position: Q1 2026 in Review

Value Aligned Research Advisors held its Astera Labs (ALAB) position steady in Q1 2026 at 568,316 shares worth $62.3M. The position accounts for 0.3% of the portfolio, ranked #50.

Value Aligned Research Advisors first reported a position in ALAB in Q1 2024 and has held it in 8 quarters since. The position peaked at $270M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Value Aligned Research Advisors held 568,316 shares of Astera Labs worth $62.3M as of Q1 2026.
  • Value Aligned Research Advisors left its Astera Labs share count unchanged in Q1 2026.
  • Astera Labs made up 0.3% of Value Aligned Research Advisors's portfolio in Q1 2026, its #50 holding.
  • Value Aligned Research Advisors first reported a position in Astera Labs in Q1 2024 and has held it in 8 quarters since.
  • Value Aligned Research Advisors's Astera Labs position peaked at $270M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Value Aligned Research Advisors's 13F filing for Q1 2026, filed 18 May 2026.